Exton, PA, United States of America

Xiaole Chen


Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Xiaole Chen

Introduction

Xiaole Chen is a notable inventor based in Exton, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of bispecific functional agents and antibody maturation systems. With a total of 2 patents, his work has the potential to impact various therapeutic applications.

Latest Patents

Xiaole Chen's latest patents include innovative methods for generating bispecific functional agents. The first patent provides a method for preparing a modular scaffold that can bind to a target antigen, along with a method for engineering a bispecific functional agent that consists of an existing polypeptide binder fused at its C-terminus with the modular scaffold. The second patent introduces a triple-mode system for antibody maturation, surface display, and secretion. This system allows for the simultaneous maturation, display, and secretion of an antibody to a target of interest, enhancing the efficiency of antibody development.

Career Highlights

Xiaole Chen is currently associated with Abzyme Therapeutics LLC, where he continues to advance his research and innovations. His work focuses on creating novel solutions that can lead to breakthroughs in therapeutic applications.

Collaborations

Xiaole Chen collaborates with talented individuals such as Hiep Tran and Christine Mary Prokopowitz, who contribute to the innovative environment at Abzyme Therapeutics LLC.

Conclusion

Xiaole Chen's contributions to biotechnology through his patents and collaborative efforts highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in therapeutic technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…